KEYNOTE SPEAKERS

Speakers

Professor Dr. Brian Kennedy

Professor Dr. Brian Kennedy

Director, Centre for Healthy Ageing Professor Departments of Biochemistry and Physiology
National University of Singapore,
Singapore.

Dr. Brian Kennedy is internationally recognized for his research in the basic biology of aging and as a visionary committed to translating research discoveries into new ways of detecting, delaying, preventing and treating human aging and associated diseases. He is a Distinguished Professor in Biochemistry and Physiology at the Yong Loo Lin School of Medicine at National University Singapore and serves as Director of (1) the Centre for Healthy Longevity at the National University Health System, (2) the Healthy Longevity Translational, and (3) the Asian Centre for Reproductive Longevity and Equality. Collectively, NUS aging research seeks to demonstrate that longevity interventions can be successfully employed in humans to extend healthspan, the disease-free and highly functional period of life.

From 2010 to 2016, Dr. Kennedy was the President and CEO of the Buck Institute for Research on Aging and he maintained a professorship there through 2020. Dr. Kennedy has adjunct appointments at the Department of Biochemistry at the University of Washington, where he was a faculty member from 2001 to 2010. In addition, Dr. Kennedy is also actively involved with a number of Biotechnology companies. In addition, Dr. Kennedy serves as a Co-Editor-In-Chief at Aging Cell. Finally, Dr. Kennedy has a track record of interaction in China, where he was a Visiting Professor at the Aging Research Institute at Guangdong Medical College from 2009 to 2014. His Ph.D. was performed in the laboratory of Leonard Guarente at M.I.T., where he published the first paper linking Sirtuins to aging.

Professor Dr. Jerome Kim

Director General
International Vaccine Institute Seoul,
South Korea

Jerome Kim, M.D., is an international expert on the evaluation and development of vaccines and is the Director General of the International Vaccine Institute (IVI), whose mission is to discover, develop and deliver safe, effective and affordable vaccines for Global Health. His depth and breadth of scientific experience span basic research through advanced clinical development. IVI’s oral cholera vaccine is used around the world to prevent this deadly diarrheal disease.  IVI’s typhoid conjugate vaccine, tech-transferred to SK bioscience and PT Bio Farma, is completing Phase III testing.  IVI is working on several different vaccines against COVID-19, including the clinical testing of Inovio’s DNA vaccine at Seoul National University Hospital and Genexine’s COVID-19 vaccine at Severance Hospital.

Dr. Kim was Principal Deputy and Chief, Laboratory of Molecular Virology and Pathogenesis in the U.S. Military HIV Research Program (MHRP) and also served as the Project Manager for the HIV Vaccines and Advanced Concepts Evaluation Project Management Offices, U.S. Army Medical Materiel Development Activity, Fort Detrick, MD.  He led the Army’s Phase III HIV vaccine trial (RV144) which was the first demonstration that an HIV vaccine could protect against infection, as well as subsequent studies that identified laboratory correlates and HIV sequence changes associated with vaccination.

Dr. Kim has authored over 300 publications and received the John Maher Award for Research Excellence from the Uniformed Services University of the Health Sciences in 2013 and the Department of the Army R&D Award for Technical Excellence (2013).  Dr. Kim is also an Adjunct Professor of Medicine at the Uniformed Services University of the Health Sciences and at Yonsei University Graduate School of Public Health and a Fellow of the American College of Physicians and the Infectious Diseases Society of America.

He is a graduate of the University of Hawaii, with high honors in History and highest honors in Biology, and received his M.D. from Yale University School of Medicine.

Professor Dr. Milan Radosavljevic

Vice-Principal and Pro-Vice-Chancellor
(Research, Innovation & Engagement)
University of the West
Scotland

Professor Milan Radosavljevic joined UWS in December 2013 as Professor in Civil Engineering before being appointed to the position of Assistant Dean Research and Enterprise in the then School of Engineering and Computing in September 2014, and University’s Associate Vice-Principal Research and Enterprise between September 2017 and May 2020. In the past, he held leadership positions across all areas of academic activity, including School Director of Teaching & Learning and School Director of Enterprise in addition to several programme leadership and course development roles at the University of Reading. He completed his PhD in Construction Management at the University of Dundee, where, subsequently, for several years he co-managed Scottish demonstration projects on behalf of Constructing Excellence and Communities Scotland.

Professor Radosavljevic has contributed his expertise at institutions globally, including the Norwegian School of Management, Tallinn University of Technology, University of Ljubljana, Shandong University, University of Cambridge, City University London, and has developed and run numerous executive courses in the UK and abroad. His research track record includes predominantly industry-led projects like Built Asset Lifecycle Intelligence (BALI), embodied energy optimisation for concrete structures, Building Information Modelling (BIM) based whole life costing, KanBIM on-site BIM platform development, and the Olympics 2012 Programme Management review, jointly with the Chartered Institute of Building (CIOB) and on behalf of the Olympic Delivery Authority.

Professor Radosavljevic co-authored one of the construction sector’s most comprehensive textbooks on construction management strategies, offering a clear theoretical framework to systematically improve its productivity. He has several years of leadership experience in off-site construction sector in Slovenia and has over the years been a regular keynote or invited speaker at international industry Project Management conferences for the Energy and Construction sectors.

As Vice-Principal, Research, Innovation and Engagement, Milan has Executive responsibility for Advancement, Enterprise and Engagement and Research including the Doctoral College.

Professor Dr. P. R. Sodani

President, IIHMR University Dean,
Institute of Health Management Research Director,
Centre for Health Economics India,
India

Prof. P. R. Sodani, has been appointed as President (Vice Chancellor) of the IIHMR University, Jaipur, India. He holds the position of Dean, Institute of Health Management Research, at the IIHMR University with more than two decades of experience in teaching, research, training, consultancy and management. He has established the Center for Health Economics at the University and is the Founder Director of the Center. He holds appointment with the Department of International Health, at the Johns Hopkins Bloomberg School of Public Health, USA for teaching MPH program. He holds PhD (Health Economics) and MPH from the University of North Carolina at Chapel Hill, USA. Area of interest includes health systems/policy, health economics/financing, quality of care. He has extensively contributed in these areas through research, training, education, consulting and networking at national and international level. He has conceptualized, designed and conducted large number of Health Systems Policy Research projects. He has developed and conducted large number of Executive Education Programs for national and international participants.

Prof. Sodani is associate editor of Journal of Health Management, a SAGE Publications and frequently receives request to review papers for national and international journals of repute. Prof. Sodani has published a book on Managing Quality in Health Care which has been widely distributed in India and abroad for public health courses. Prof. Sodani has worked on various assignments for Johns Hopkins University, World Bank, WHO, BMGF, GAIN, UNFPA, UNICEF, Development Partners, and Governments.

Prof. Sodani is Secretary-General of the South East Asia Public Health Education Institutions Network (SEA PHEIN). The network (SEAPHEIN) is supported by WHO-SEARO, to promote and encourage public health education movement in South-East Asia Region. Prof. Sodani has been instrumental in establishing the India Public Health Education Institutions Network (IndiaPHEIN) and hold the position of Secretary to IndiaPHEIN.

Professor Dr. Sarah Wamala Andersson

Health and Welfare Technology Mälardalens University
Previous Director-General of the Swedish Public Health Agency
Sweden

Dr. Sarah’s passion is to translate science into practice and contribute to making a difference in real life using scientific results and contribute to sustainability. She has spent a substantial amount of working life outside academia, which has given her a unique opportunity to observe critical research gaps faced by providers, payers, decision-makers, and the private sector.

 *Previous experience (selection):

  • Principal research scientist for several multi-national pharmaceutical companies regarding real-world evidence for new innovative medical treatments and technologies
  • Director-General of the Swedish Public Health Agency (Swedish Ministry of Health and Social Affairs)
  • Professor of Health Policy and Management (Karolinska Institutet)
  • Director of Health Promotion and Disease Prevention (Stockholm County Council).

Dr. Sarah acquired academic training from various international universities (Ph.D. in Medical Sciences, a Master’s degree in Biostatistics and a Bachelor’s degree in Economics), as a guest research scientist at Wellington School of Medicine (New Zealand), and completed the Stanford Executive Program (SEP) from Stanford Graduate School of Business, USA.

She believes in mindset being everything and human interconnectedness as the basis for innovation and productivity in a sustainable way. Dr. Sarah is the author of the recent book – Shift your mind and make yourself great again.

Professor Shai Reshef

Founder & President University of the People, California,
USA

Shai Reshef is the President of University of the People (UoPeople) —the world’s first non-profit, tuition-free, American accredited, online university. UoPeople is the Education Revolution. It offers high quality, accessible, affordable American degrees through a groundbreaking online learning model. With volunteers from the world’s foremost academic institutions, UoPeople allows students the flexibility they need to earn college and graduate degrees and to build brighter futures, whoever and wherever they are.

An educational entrepreneur, Shai has over 25 years of experience in the international education market. From 1989 to 2005, he served as Chairman of the Kidum Group, a for-profit educational services company. Between 2001 and 2004, Reshef also chaired KIT eLearning, the online learning partner of the University of Liverpool and the first online university outside of the United States.

Shai has been widely recognized for his work with UoPeople, including being named one of Fast Company’s 100 Most Creative People in Business; selected by OneWorld as one of its ‘People of 2009;’ awarded an Ashoka fellowship; joined UN-GAID as a High-level Adviser; selected by The Huffington Post as the Ultimate Game Changer in Education; nominated as one of Wired Magazine’s 50 People Changing the World; and selected as a Top Global Thinker by Foreign Policy Magazine. Global media coverage includes the New York Times, Washington Post, Chronicle of Higher Education, NPR, and more.

An expert at the intersection of education and technology, Shai has spoken internationally at numerous conferences including TED; DLD; TEDxOxbridge; World Economic Forum; EG5 Conference; TEDxKC; Google’s Higher Education Summit; EMV Human Values meeting; The Economist’s Annual Human Potential Summit and the Schools for Tomorrow Event for the New York Times. He has lectured at Yale, Harvard, Stanford and Oxford, among others.

Dr. Ahmed Ogwell Ouma

Deputy Director
Africa Centres for Disease Control and Prevention
Africa

Dr. Ahmed OGWELL OUMA is an accomplished international civil servant and an expert in global health for over 25 years. He has competency in governance in public health; partnerships and resource mobilisation; health security including health emergencies; the prevention and control of NCDs; building multi-sectoral partnerships; international co-operation across sectors; tobacco control; global health diplomacy; and development of international instruments that impact positively on public health.

Ahmed has worked globally for public health and has overseen implementation of numerous health policies in countries in Africa. He has been a pioneer in supporting governments in Africa to implement the WHO Framework Convention on Tobacco Control (WHO FCTC) and other international instruments for the prevention and control of NCDs.

Most recently, Ahmed was an Advisor in the Global Coordination Mechanism for NCDs in the Office of the Assistant Director-General for NCDs and Mental Health in W.H.O in Geneva. Before that he was Programme Manager for Primary Prevention of NCDs and Regional Adviser for Tobacco Control at the WHO Regional Office for Africa.

At the national level, Dr Ogwell was the founding director for the NCDs in MoH Kenya and also established the Office for International Health Relations.

He has expertise in how government policy can and should respond to neglected health challenges. Having been a senior civil servant in Kenya for over a decade, he is well versed in how governments work, competence in supporting government to achieve desirable public health goals particularly in resource-poor settings.

He is the current Deputy Director at Africa CDC, a technical agency of the African Union.

Ahmed is an alumni of the University of Nairobi and the Centre for International Health at the University of Bergen in Norway.

Dr. Prasun Mishra

Dr. Prasun Mishra

President, American Association for Precision Medicine Founder and CEO Agility Pharmaceuticals,
San Francisco,
USA

Dr. Mishra (formerly with Genentech, Roche, NCI, NIH, DHHS, US Government) is the founding president and CEO of American Association for Precision Medicine (AAPM) and chair of ACT: AAPM Coronavirus Taskforce, leading research efforts focused on preventing and curing COVID-19, cancer, and other chronic diseases; not only treating the sick but also providing knowledge/tools to individuals to live longer, healthier lives. He is a serial entrepreneur who founded his first company after graduating high school, and second company while earning his PhD. Since then, he has accumulated a wealth of experience by building, investing, and advising numerous companies. He is an investor, co-founder/board member of a few corporations, focused on accelerating drug discovery/development, data-analytics, robotics, mental health, and digital health.

Widely recognized as a Technology and Healthcare thought leader, Dr. Mishra has keynoted, chaired, and organized numerous successful international conferences. His research work has been recognized globally by over 40 prestigious awards and honors. Dr. Mishra also served as a Scientist and Principal Investigator at Genentech, Roche. Moreover, his passion for drug development and precision medicine has led to identification of new drug targets, biomarkers, companion diagnostics, and several drugs/ combinations in the clinic. Due to his unique perspective and selfless service, he is highly respected and sought-after mentor to many.

Dr. Stephen Chu

Fellow
Australian Institute of Digital Health
Australia

Dr Stephen Chu is a practicing Clinical Informaticist who leads a number of international ehealth standards projects including Health Level 7 (HL7) Allergy/Intolerance, Adverse Reaction, Care Plan, Health Concern and Referral FHIR (Fast Health Interoperable Resources) development. He also has extensive clinical experiences in a variety of clinical domains including orthopaedics, general medicine and emergency medicine. He is a co-chair of HL7 Patient Workgroup since 2010 and is one of the international experts in the IHE (Integrating Healthcare Enterprise) and HL7 Pharmacy Workgroups; and the chief clinical informatician in Australia. He had previously served in professorial positions in the Multi-Media University of Malaysia, University of Auckland and also La Trobe University of Australia.

Professor Dr. Gang-Ming Zou

University of Hawaii at Manoa
President & Editor-in-Chief
American Journal of Translational Medicine
USA

Gang-Ming Zou has completed his Ph.D. in 2001 from Paris VI University in France and postdoctoral studies from University of Chicago and Johns Hopkins University School of Medicine in USA. He once served as a Scientific Review Officer (SRO) in NIH before he moved to Shanghai in 2009. He has been listed in “Who’s Who in the World, Marquis” Since 2010. He was the professor and principal investigator (PI) in Shanghai Cancer Institute, and Shanghai Institute for Pediatrics Research, Shanghai Jiao Tong University in China. He has published more than 30 papers in reputed journals, including PNAS, Blood, Oncogene, and Stem Cells etc, His accomplishment include that he identified the relevance between Pu.1 level and early B cell development, and Redox factor Ape1 in stem cell differentiation etc. Currently, his funded research is focusing on VSEL biology and stem cell in liver regeneration; and pancreatic cancer stem cell biology. In 2014, he returned to USA to found “American Journal of Translational Medicine” for publication through Hawaii Gangze Inc. a publisher located in Honolulu. Currently he is Editor-in-chief for American Journal of Translational Medicine. He is also a Professor in Chaminade University in Honolulu, USA, since 2021. He was the founder and Conference Chair for 1st an 2nd International Conference of Translational Medicine in Hawaii (2019, and 2020).